November 16, 2021
Strategic relationship between SCIEX and RedShiftBio® expands the reach of disruptive technology to address challenges with rapid secondary structure assessment of biotherapeutics
SCIEX to provide Microfluidic Modulation Spectroscopy (MMS) solutions for in-depth characterization of key attributes of biotherapeutics
November 01, 2021
SCIEX and Evosep will collaborate to provide robust, high-throughput proteomics workflows
November 01, 2021
SCIEX targets new category of analytical instrumentation to help biopharma scientists close the developability gap
icIEF-MS accelerates biotherapeutic development through identification of charge variants at the intact protein level
September 01, 2021
SCIEX presents industry first multi-capillary system for CE-SDS, the BioPhase 8800 system
Instrument ushers in a new phase of biologic characterization, empowering scientists to analyze more samples and molecules to meet next-gen drug development challenges
September 01, 2021
SCIEX builds on cadence of innovation in biopharma with Biologics Explorer
New application software enables protein characterization analysis for the ZenoTOF 7600 system
July 29, 2021
Strategic partnership between Genedata and SCIEX deepens and accelerates characterization of next generation biotherapeutics
The collaboration will drive the development of new software solutions for in-depth characterization of novel biotherapeutics during the drug development process.
June 17, 2021
SCIEX presents new accurate mass instrument, the ZenoTOF 7600 system
System delivers new capabilities for life science research and biotherapeutic development through novel ion fragmentation and increased sensitivity
June 17, 2021
SCIEX OS introduces new software with OneOmics suite and Molecule Profiler app
New introductions connect breakthrough technology to biological insight in a secure, cloud-based environment
May 11, 2021
SCIEX and Waters Corporation collaborate up to deliver fully configured and interoperable LC-MS systems
April 01, 2021
SCIEX appoints Joe Fox as President
January 21, 2021
SCIEX Acquires Intabio, a developer of precision solutions for biotherapeutic analysis through imaged cIEF-MS
Innovative charged variant analysis accelerates biologic drug development, ensuring drug safety and efficacy